$1.00
-0.01 (-0.99%)
StemCells, Inc. (NASDAQ:STEM)
CAPS Rating:
A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.
RSS Headlines
Fool UK